1. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (954)
  2. Meeting Abstract (771)
  3. Book Section (42)
  4. Editorial (32)
  5. Review (26)
  6. Research Letter (15)
  7. Guidelines (6)
  8. Correspondence (5)
  9. Conference Paper (4)
  10. Miscellaneous (3)
  11. Book Whole (2)
Groups
  1. Department of Medicine (1860)
  2. Melanoma and Immunotherapeutics Service (1860)
  3. Solid Tumor Oncology Division (1860)
  4. GSK Faculty (1050)
  5. Melanoma Disease Management Team (782)
  6. Hematologic Malignancies, Division of (507)

More Groups

People
  1. Jedd Wolchok (905)
  2. Taha Merghoub (364)
  3. Michael Postow (361)
  4. Paul Chapman (326)
  5. Alexander Shoushtari (244)
  6. Margaret Callahan (197)

More People

Years
  1. 2025 (22)
  2. 2024 (46)
  3. 2023 (66)
  4. 2022 (125)
  5. 2021 (112)
  6. 2020 (122)

More Years

Publications
  1. Journal of Clinical Oncology (330)
  2. Journal for ImmunoTherapy of Cancer (131)
  3. Cancer Research (106)
  4. Clinical Cancer Research (90)
  5. Annals of Oncology (77)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (43)

More Publications

Publishers
  1. American Society of Clinical Oncology (342)
  2. American Association for Cancer Research (274)
  3. Biomed Central Ltd (148)
  4. Elsevier Inc. (144)
  5. Oxford University Press (109)
  6. Nature Publishing Group (88)

More Publishers

Results (1860)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety of influenza vaccination in patients undergoing immunotherapy treatment for advanced cancer
    Meeting Abstract

    Chong, C. R.; Park, V.; Harding, J. J.; Brite, J.; Wolchok, J. D.; Kamboj, M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Nivolumab monotherapy in metastatic urothelial carcinoma: Longer-term efficacy and safety results from the CheckMate 032 study
    Meeting Abstract

    Sharma, P.; Callahan, M. K.; Bono, P.; Kim, J. W.; Spiliopoulou, P.; Calvo, E.; Pillai, R. N.; Ott, P. A.; De Braud, F. G.; Morse, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Rates of ERBB2 alterations across melanoma subtypes and a complete response to trastuzumab emtansine in an ERBB2-amplified acral melanoma
    Journal Article

    Gottesdiener, L. S.; O'Connor, S.; Busam, K. J.; Won, H.; Solit, D. B.; Hyman, D. M.; Shoushtari, A. N.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Computed tomography-derived assessments of regional muscle volume: Validating their use as predictors of whole body muscle volume in cancer patients
    Journal Article

    Halpenny, D. F.; Goncalves, M.; Schwitzer, E.; Golia Pernicka, J.; Jackson, J.; Gandelman, S.; Moskowitz, C. S.; Postow, M.; Mourtzakis, M.; Caan, B.; more...
    British Journal of Radiology (2018)

    Fulltext@MSK | Save
  • A phase 1 clinical trial of ipilimumab, nivolumab and radiation therapy for patients with metastatic melanoma
    Meeting Abstract

    Barker, C. A.; Postow, M. A.; Goldman, D. A.; Panageas, K. S.; Halpenny, D.; McCabe, D.; Macri, M.; Schwarzenberger, P.; Ricciardi, T.; Ryan, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Outcomes of uveal melanoma with distant metastasis at initial staging: Impact of primary tumor therapy
    Meeting Abstract

    Modlin, L. A.; Kuriakose, R. K.; Francis, J. H.; Abramson, D. H.; Shoustari, A. N.; Barker, C. A.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Safety and clinical outcomes of ipilimumab and nivolumab plus concurrent stereotactic radiosurgery for brain metastases
    Meeting Abstract

    Johnson, C. B.; Postow, M. A.; Chapman, P.; Wolchok, J. D.; Brennan, C. W.; Tabar, V. S.; Chan, T. A.; Yamada, Y.; Yang, T. J.; Beal, K.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Acetaminophen immediate release pharmacokinetics in iatrogenic overdose
    Meeting Abstract

    Yip, L.; Dart, R. C.; Spyker, D. A.; Chapman, P. B.
    Clinical Toxicology (2018)

    Fulltext@MSK | Save
  • The dietary supplement chondroitin-4-sulfate exhibits oncogene-specific pro-tumor effects on BRAF V600E melanoma cells
    Journal Article

    Lin, R.; Xia, S.; Shan, C.; Chen, D.; Liu, Y.; Gao, X.; Wang, M.; Kang, H. B.; Pan, Y.; Liu, S.; more...
    Molecular Cell (2018)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
    Journal Article

    Hodi, F. S.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Rutkowski, P.; Cowey, C. L.; Lao, C. D.; Schadendorf, D.; Wagstaff, J.; Dummer, R.; more...
    Lancet Oncology (2018)

    Fulltext@MSK | Save